It triggers the release of insulin, which helps to regulate blood sugar levels, slow digestion and increase feelings of fullness.[1][2] These effects are why GLP-1-based medications (such as Mounjaro and Ozempic) have become so widely used in the management of type 2 diabetes and weight loss
Dont assume discomfort is normalcheck with your provider
While some clinics only offer weight loss medications that leave you with reduced muscle tone and excess skin, we help you refine and feel confident in your new silhouette
Przyjmowanie analogu GLP-1 wizao si ze wzrostem wystpowania czstoskurczw komorowych lub migota komr (13 vs
Blood sugar: Without the medication helping your pancreas release insulin, blood sugar levels can rise again if lifestyle changes aren't maintained
Last month (May 2025), Novo announced that the US Food and Drug Administration (FDA) accepted its new drug application (NDA) submission for an investigational once-daily oral formulation of Wegovy (semaglutide) for chronic weight management in adults living with obesity or overweight with one or more comorbid conditions and to reduce the risk of major adverse cardiovascular events in adults with overweight or obesity and established cardiovascular disease